Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic Review

September 3, 2017 at 6:40 pm

Open Forum Infectious Diseases April  2017 V.4 N.2

Reese A. Cosimi; Nahal Beik; David W. Kubiak; Jennifer A. Johnson

This article reviews and evaluates the existing literature describing clinical outcomes and safety of ceftaroline in severe methicillin-resistant Staphylococcus aureus infections.

Ceftaroline is approved by the Food and Drug Administration for acute bacterial skin and skin-structure infections and community-acquired bacterial pneumonia, including cases with concurrent bacteremia. Use for serious methicillin-resistant Staphylococcus aureus (MRSA) infections has risen for a multitude of reasons.

The aim of this article is to review the literature evaluating clinical outcomes and safety of ceftaroline prescribed for serious MRSA infections. We conducted a literature search in Ovid (Medline) and PubMed for reputable case reports, clinical trials, and reviews focusing on the use of ceftaroline for treatment of MRSA infections.

Twenty-two manuscripts published between 2010 and 2016 met inclusion criteria. Mean clinical cure was 74% across 379 patients treated with ceftaroline for severe MRSA infections. Toxicities were infrequent. Ceftaroline treatment resulted in clinical and microbiologic cure for severe MRSA infections. Close monitoring of hematological parameters is necessary with prolonged courses of ceftaroline.

PDF

https://watermark.silverchair.com/api/watermark?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAdMwggHPBgkqhkiG9w0BBwagggHAMIIBvAIBADCCAbUGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMvnqvVinRP8PvAJRgAgEQgIIBhlKCsxJw2TOe_6entYFWKf2-BkLTzr93n2tNH8boO2PS2YUg-9vu5Q-L-DJpmzM7DybrlX_pwpnbZFdudrBmCQLL7seS64Dye4f4yKrP77NOfRvdjaUZMK-XLaJd8ErFzBbnr1-N-mOL8-kV83A6A4ITJAdm8Jq9jzOeIYCQwN0PLNKB–odW_WZPmol9Ejhni7qBlP3YCDpy1gltUPWl85dzPkEUP5b8SI5YMO4kTIdJ0HFk1nICzg0YUJEaiNJ-mRByK5miWMV3xJ4pKL2dE8qJB76Ah4__m-y0tHUeCCo6PUPBPL8VP96DvLgEwq_ux-IqDFe9PQ-YOno9txJIBaClm1VFTVmntQVKbnVMZUZVLiby8OXf7h336QP126S-9bqm5Zep_P3AUddt2BMeOYVdTXEqYFqH3Ch1bU1BoAWzxP0qErq5CWsrFehfhmyZ6FjysnivJ4s4eOlfVpvraLyxP4DxmWsGWQ3SFytnkwhliMVF1t6jAJO7SyQ0kYSe5ITzz5Fvg

Advertisements

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Epidemiología, Metodos diagnosticos, REPORTS, Resistencia bacteriana, REVIEWS, Sepsis, Update.

Vaginal seeding or vaginal microbial transfer from the mother to the caesarean-born neonate: a commentary regarding clinical management Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis


Calendar

September 2017
M T W T F S S
« Aug   Oct »
 123
45678910
11121314151617
18192021222324
252627282930  

Most Recent Posts


%d bloggers like this: